What Healthcare Organizations Miss When It Comes to Reimbursement Accuracy
At the end of the day, the most important question is a simple one: Do you actually know if you’re being reimbursed correctly?
Better Prescribing, Not Less Prescribing, Is What Behavioral Health Needs
The policy conversation needs to shift from just deprescribing alone to building the clinical infrastructure that delivers consistent, high-quality behavioral health care.
You Can Now Bet on Clinical Trials Like Playoff Games, But Health Execs Say It Crosses a Line
Prediction market Kalshi launched betting markets tied to clinical trial results and FDA approvals. Healthcare leaders warn the model could invite insider trading and distort the integrity of the research outcomes it's meant to forecast.
New Bill Seeks to Create Public Option on ACA Marketplaces
Rep. Angie Craig introduced a bill to establish a public health insurance option on the ACA marketplaces and permanently extend enhanced premium tax credits.
Agios Pharma Drops Sickle Cell Disease Drug After Phase 2 Data Disappoint
Agios Pharmaceuticals said tebapivat fell short of expectations in a Phase 2 test in sickle cell disease. It’s the latest in a series of disappointing industry developments in sickle cell disease.